ASB Consultores’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
+6,119
| New | +$220K | 0.15% | 132 |
|
|
2024
Q2 | – | Sell |
-11,798
| Closed | -$358K | – | 273 |
|
|
2024
Q1 | $358K | Buy |
+11,798
| New | +$358K | 0.09% | 169 |
|
|
2023
Q3 | – | Sell |
-9,572
| Closed | -$294K | – | 185 |
|
|
2023
Q2 | $294K | Buy |
9,572
+26
| +0.3% | +$799 | 0.14% | 134 |
|
|
2023
Q1 | $344K | Buy |
9,546
+1,465
| +18% | +$52.8K | 0.14% | 114 |
|
|
2022
Q4 | $319K | Buy |
8,081
+2,255
| +39% | +$89.1K | 0.13% | 119 |
|
|
2022
Q3 | $234K | Hold |
5,826
| – | – | 0.11% | 150 |
|
|
2022
Q2 | $245K | Sell |
5,826
-331
| -5% | -$13.9K | 0.11% | 134 |
|
|
2022
Q1 | $240K | Buy |
+6,157
| New | +$240K | 0.1% | 184 |
|